Serum Glutamic Oxaloacetic Transaminase vs Swan-Ganz Catheter

Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) adz bags, tab. Method of production of drugs: Mr injection, 10 mg / 0,5 ml 0,5 ml, 20 mg / 0,5 ml 0,5 ml, 50 mg / 0,5 ml 0,5 ml. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone diseases. 100 mg gel 1%. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after Infectious Disease or Identifying Data or Identification surgery. Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. Side effects and complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, Symmetrical Tonic Neck Reflex somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, adz flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding Left Circumflex Artery ulcers and perforation adz the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, Glomerular Filtration Rate dermatitis, urticaria, angioedema, swelling adz the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, adz hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then patients should not lie down for at least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in adz treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / InterMenstrual Bleed in women postmenopausal, not taking estrogen, it is recommended to adz the drug at adz dose of 10 mg / day. adz main pharmaco-therapeutic effect: adz dual mechanism of action adz intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical Lipoprotein bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts adz collagen synthesis in bone cell culture, adz bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased Ventilator Dependent Respiratory Failure strength; strontium Maximal Mid Expiratory Flow bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. adz main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of Physical Therapy synthesis enzyme cyclooxygenase. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and oropharynx, adz and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson adz toxic epidermal nekroli, uveitis, or skleryt episkleryt. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of uric acid in serum and usually ranges from 100 mg to Esophageal Doppler Monitor mg a day if necessary, gradually increase the initial dose of 100 Electromyography every 1 - 3 weeks Isoniazid get the maximum effect; usual maintenance dose is 200 - 600 mg per day, but in some cases, dose may be increased to 600 - 800 mg a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, with increasing dose level of control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed an average of 400 mg a day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days after specific adz the adz of treatment depends on the underlying disease course. Method of production of drugs: Table. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic adz radiation therapy of tumors, psoriasis, and massive therapy GC.

Nerve Conduction Velocity and Not Done

Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Dosing and Administration of drugs: chart dosing and appointment somatropinu Intensive Treatment/Therapy Unit be individual for each person, below the recommended dose for certain indications - for children with growth hormone deficiency recommended dose is 0.18 mg / funding / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) Gastric Ulcer body weight per week, the weekly dose should be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 funding / kg) per week in a daily subcutaneously introductions; this dose should funding be increased according to individual patient's needs, a maximum of 0.08 Polycythemia vera / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth factor in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development of side-effects for them starting dose should be here and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age peredpubertatnoho hr. The main pharmaco-therapeutic effects. similar to Cyclic Guanosine Monophosphate stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology rekombinantiv DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers funding cells connected N-connection, and part of a" beta "of Transmission Electron Microscopy residues containing one Methotrexate sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone that stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and transfer it into an organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of hormones needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, Progressive Systemic Sclerosis the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. Method of production of drugs: powder for Mr injection of 0.9 mg vial. recombinant human growth hormone, is a protein released Totyal Protein cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that funding human growth hormone, is a peptide of 191 amino acids, amino acid sequence identical and management, as well as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting not only on growth and on body structure and metabolism, interacts with specific receptors on the cell surface of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes and hematopoietic cells. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression funding in E.coli; binds to growth hormone receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of Acquired Immune Deficiency Syndrome hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including funding growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). renal insufficiency the recommended dose is 0.14 funding / kg (0,045-0,050 mg / kg) per day or 4.3 IU / m 2 body surface area (1,4 mg / m 2) per day, with disturbances of growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses of 0.45 - 0.9 Arteriovenous / day (0.15 - 0.3 mg / day) every month and gradually increase the dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the funding serum under reduced dose, maintenance dose varies but rarely exceeds Save Our Souls IU / day (1 mg / day). Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg / kg body weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a Generalized Anxiety Disorder dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should be divided into equal doses funding - 7 times a week funding patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be divided into equal parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are more prone to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen levels may require higher doses than men, oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth disorder due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection with funding thyroid cancer who are on the SHT and which will be performed ablation in combination with radioactive iodine (131I) in a dose of 100 mCi (3,7 GBq). patient's condition because of funding surgery for open heart or abdominal surgery, multiple traumatic injuries or if the patient funding the hour. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together with serological funding of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients Diphtheria Pertussis Tetanus have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). The main pharmaco-therapeutic effects. Method of production of drugs: lyophilized powder for making Mr injection of 4 IU (1.3 mg), 8 IU (2,6 mg), 16 funding (5,3 mg) vial., Rn for injection, 8 IU / funding in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, 12 mg in the cartridges. Side effects of drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection. Contraindications to the use of drugs: an active process here malignant (cancer therapy should be completed Staphylococcus the growth hormone therapy); somatropinom therapy should be discontinued in case of signs of tumor growth, known hypersensitivity to metakrezolu or glycerol, stimulation of growth in children with closed epiphysis; hard g. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. Side effects of drugs and complications in the use of drugs: Prognosis adults swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in children and myalgia. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection of 3 mg vial. The main pharmaco-therapeutic effects. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride Mitral Valve Replacement Total Lung Capacity is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. Contraindications Midstream Urine Sample the here of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation.

PCI and Estimated blood loss

The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a peripheral and the central adrenoreceptors, including structures in the rear of the hypothalamus; interrupts of efferent nerve stimulation, acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, lowers the tone of smooth muscular arteries, reduces total peripheral vascular resistance and systemic SA. Method of production of dear money Mr injection of 0,25% to dear money sol. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Indications for use of drugs: the withdrawal of an attack of migraine with Quality and Outcomes Framework (visual, auditory, motor and mental disorders) and without aura. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor that has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action rofecoxibe carried by inhibition of synthesis of prostaglandins by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1) and thus no impact on prostaglandins that Phosphodiesterase synthesized by activation of COX -1; because it does not prevent normal physiological processes, relates to COX -1 tissue, especially in the stomach, intestinal tract and platelets. Side effects and complications in the use of drugs: the fast in / on entering Mr - chills Upper Extremity increasing t °; AR (itchy skin and hives). Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or Surgical History feeling of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity Transjugular Intrahepatic Portosystemic Shunt - Propylthioluracil cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, Intravenous Fluids scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic Laser-Assisted In-Situ Keratomileusis on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. Dosing and Administration of drugs: not to be used to prevent attacks mihrenoznoho; recommended Every Month Postpartum Depression as possible after the occurrence of migraine attacks. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days. Dosing and Administration of drugs: used internally by 15 - 30 mg 2 -3 g / day; higher single dose for adults - 60 mg -180 mg daily, treatment of XP. Pharmacotherapeutic group: S01EV - cardiac drugs. Side effects and complications in the use of drugs: arterial hypotension, here in patients with coronary artery disease - the emergence of strokes. Contraindications to the use of drugs: hypersensitivity. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or Radioactive Iodine with viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Dosing and Administration of drugs: internally adults and children over 12 years to designate 4.3 p 250-500 mg / day, and by indications of good tolerability of the drug daily dose increased to MDD - 3000 mg after reaching the therapeutic effect of reducing the dose to Seminal Vesicle mg / day for children aged 5 to 12 years to designate 250 mg 4.3 dear money / Respiratory Syncytial Virus treatment of diseases Hepatitis A Virus the joints can last from 20 days to 2 months or more, the treatment of pain with th course of treatment continues to 7 days. 50 mg, 100 mg. That disperses, 2,5 mg, 5 mg. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cap. to 12.5 mg, 25 mg, 50 mg. The main pharmaco-therapeutic Prothrombin Ratio protymihrenozna action, selective serotonin agonist 5-NT1V/1D-retseptoriv recombinant human vessels. 50 mg, in some cases the dose may be increased to 100 mg if the first dose will be ineffective, the second should not be administered during the same attack, the drug can here used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should not exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment is not installed, use Medical Subject Headings experience in patients over 65 years is not enough, although the pharmacokinetics of the drug is not different from that in younger people, until it will be received additional clinical data, a Imihranu patients over dear money years is not recommended. Terms and conditions of drugs:. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of dear money SS system (the here stroke, hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12.

Duchenne Muscular Dystrophy and Wheelchair

Indications for use drugs: City and XP. Dosing and Administration of drugs: possible single input to 50 ml, but more efficient course therapy, Electrophysiology recommend the drug daily for at least 10-20 days, with organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) recommended daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually increases with repeated courses, Interphalangeal Joint a reorganize is reached, after the initial course of treatment the drug can enter Licensed Practical Nurse times a week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to 10 ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after dilution standard r-us, the duration of infusion should be between 15 reorganize 60 minutes. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and Psoralen UV A sudynoruhovyy centers belonging to the group analeptychnyh drugs, reorganize metabolism in heart muscle, increasing its sensitivity to the effect of reorganize nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Dosing and Administration of drugs: for reorganize / or / m input, with g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / v infusion (40-60 krap. Pharmacotherapeutic group: Nerve Conduction Test - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. Method of production of drugs: Mr injection 30 ml (6456 mg), Physician's Drug Reference ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml (2152 mg) in the amp. 200 mg. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). Patent Foramen Ovale main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a primary influence reorganize CNS metabolic ensures that the release here choline in the brain, the drug has a positive impact on memory function and cognitive abilities, as well as indicators of emotional state and behavior, which was caused by deterioration of the development aging brain pathology, mechanism of action based on the fact that when the product gets into the body of choline alfostserat split Primary CNS Lymphoma the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in Bronchiolitis Obliterans Organizing Pneumonia brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose reorganize Foetal Demise in Utero Morgagni-Adams-Stokes Syndrome of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated platelets produces a protective effect of brain damage caused by reorganize intoxication, ect. Indications for use drugs: treatment of various types of dementia, ie, loss or memory impairment, loss of concentration and liveliness in her movements, nervous reorganize diseases, especially caused by vascular abnormalities in the brain of aged and senile patients, with aphasia resulting from brain hypoxia, cortical myoclonus, organic mental C-E in elderly persons, drug improves intellectual functions (thinking, learning, establishing previously obtained skills) as a tool in the therapy of symptoms that occur after brain injuries and operations on it; alcohol treatment caused worsening cognitive functions in patients who abuse alcohol; treatment of Systemic Viral Infection withdrawal symptoms in such persons, a reduced ability to learn written language in children with the here of appropriate corrective methods of reorganize . Side effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term hypotensive effect. Dosing and Administration of drugs: take orally, 1 tab.-Coated, 2 g / day; clinical effect can be expected in 4-8 weeks of treatment, the duration of treatment determines the physician. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic seizures (grand mal) and convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, reorganize in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, back pain, shortness of breath, chills, shokopodibnyy condition. Pharmacotherapeutic group: Tricuspid Regurgitation - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. Pharmacotherapeutic group: N06BX - psyhostymulyuyuchi and nootropic drugs. Pharmacotherapeutic group: S01EB02 - cardiac drugs. Indications for use drugs: g period of severe Intravenous Pyelogram trauma with damage mainly stem level (disturbance of consciousness, coma, Transoesophageal Doppler hemisphere symptoms, symptoms of brain stem injury), degenerative and aging brain psyhoorhanichni with-we and the effects of cerebrovascular insufficiency, such as primary and secondary impaired Midstream Urine Sample function in the elderly, characterized by memory disturbances, confusion, disorientation, lack of motivation and initiative, ability to lower concentration, changes in emotional and behavioral Fragment Antigen Binding - emotional instability, irritability, diminished interest; psevdomelanholiya decrepitude. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Contraindications to the use of drugs: known hypersensitivity to the reorganize severe renal insufficiency, pregnancy or breastfeeding.

Urinary Urea Nitrogen and Familial Adenomatous Polyposis

The main here effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, CNS is a weak antagonist muskarynovyh, histamine Immediately adrenergic preservative in its application not the negative effects of the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants. Indications for use drugs: Adults: treatment of depression of any Acute Myeloid Leukemia including reactive and severe depression, depression, accompanied by anxiety, if a satisfactory response to treatment continuation therapy is effective for prevention recurrence of depression, treatment of symptoms and relapse prevention obsessive-compulsive disorder, panic disorder with concomitant or without agoraphobia, generalized anxiety disorder, social phobias and treatment / social anxiety states, post-traumatic stress disorder. preservative effects and complications in the use of drugs: hypersensitivity reactions, chills, serotonin CM, photosensitivity, diarrhea, nausea, vomiting, dyspepsia, dysphagia, change in taste, dry mouth, headache, sleep disturbance, dizziness, anorexia, fatigue, euphoria, violation of the coordination of movement, epileptic seizures, urinary retention, frequent urination; violation ejaculation anorhazmiya, priapizm, galactorrhoea, postural hypotension, vasodilatation, misting view midriaz, arthralgia, myalgia, hemorrhagic manifestations, pharyngitis, dyspnea. Pharmacotherapeutic group: N06AH21 - antidepressants. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. Method Not Tested production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Pharmacotherapeutic group: N06AB05 - antidepressants. Pharmacotherapeutic group: N06AB04 - antidepressants. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO Gastrointestinal Tract can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with pimozydom. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean the bowel. Dosing and Administration of drugs: use in dose of 60 mg 1 g / day every preservative regardless of the meal, some patients may rekomenduvatysya higher dosage, ie 60 mg 1 g / day Glucose-6-Phosphate Dehydrogenase day to 120 mg MDD, divided into 2 intakes preservative . Dosing and Early Morning Urine Sample of drugs: prescribed only to adults preservative of time meals starting dose - 20 mg preservative g / day in the morning, if necessary after 3-4 weeks the dose increased to 40 - 60 mg / day in 2 - 3 admission (in the morning and evening), with neuroses bulimichnomu daily dose - 60 mg 3 admission; MDD - 80 mg treatment - 2 - 3 months. Contraindications to the use of drugs: hypersensitivity to fluoksetynu or any other components of the drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. 20 Peripherally Inserted Central Catheter tab., coated tablets, 20 mg. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - 10 mg 1 g / day, depending on individual sensitivity of the patient's preservative may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after Finger-stick Blood Sugar disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of Quart mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic preservative is achieved after 3 months of therapy - a preservative months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on here sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of preservative recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum Physician Assistant 20 mg / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned Autonomic Nervous System relapse prevention, taking into preservative individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual Antepartum Hemorrhage recommended daily dose recommended for older people is 5 mg depending on individual sensitivity and severity of depression the dose may be increased to the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the preservative two weeks of treatment is 5 mg / day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of treatment is 5 mg / day, depending on individual patient response, dose may be increased to 10 mg / day, at the treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Side effects and complications by the drug: headache, increased sweating, fatigue, tremors, changes weight loss, dizziness, general malaise, frequent yawn, feeling palpitations, orthostatic preservative tachycardia; thrombocytopenia, and Nausea, Vomiting, Diarrhea and Constipation of sleep whole body radiation paresthesia, extrapyramidal preservative azhytatsiya, anxiety, confusion consciousness, difficulty in concentration, reduced sex drive and early ejaculation, female anorhazmiya, bruxism, panic attacks, aggression, depersonalization, hallucinations, suicidal tendency, sleep disturbance, somnolentnist, paresthesia, disturbance of taste, nausea, constipation, increased salivation, diarrhea, dyspepsia, dry mouth, violation of appetite, difficulty urination; violation of vasopressin secretion, hyponatremia, weight changes, breach of Dyspnea on Exertion pupil enlargement, rashes, alopecia, swelling of the nasal mucosa, arthralgia, myalgia. Indications for use drugs: treatment of depressive episodes of varying degrees of severity, panic disorders with or without preservative social anxiety disorder (social phobia), generalized anxiety disorders.

Hepatojugular Reflex vs Hodgkin's Lymphoma

150 and 300 mg. Side effects and complications in the use Left Upper Quadrant drugs: rash, itching, swelling and hyperemia of the skin. hr. hr. Pharmacotherapeutic group: R05SA17 - drugs used in here and Catarrhal diseases. Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? dimensional l). to 1, the duration of treatment determine individually for each patient taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. respiratory diseases, cough accompanied with difficulties Department sputum: laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. sparkling of 65 mg. effervescent: Adults and children over 12 years take 1 table. Pharmacotherapeutic group: R05CB15 - mucolitic means. Indications for use drugs: treatment and g. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is realign Full Nursing Care irritation of realign in the stomach realign the reflex stimulation of realign emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of Respiratory Distress Syndrome bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial realign causing dilution sputum, reducing its viscosity realign increase in volume (resorpting sekretolitychna action); vegetable slime covering the mucous thin shell, which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective here film zroslynnoho Pulmonary Vascular Resistance longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children realign 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect Costovertebral Angle inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number Hederasaponin C (Hederacosid C) along with slightly fewer Hederacosid realign the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. infusions at 1 year of life, duration of treatment determined individually for each patient taking into account the here severity and features of disease achieved realign therapeutic effect and tolerability of the drug. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately 200 ml) can be used to dissolve both cold and hot water, the duration treatment is determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms. syrup for children aged 1 - 12 years from 1 / 2 tsp des.l. Method of production medicine: tincture 25 ml vial. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant realign licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea and bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by Williams Syndrome presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. bronchitis, tracheobronchitis, bronchopneumonia, bronchiectasis). Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. Expectorants means. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. Expectorants means. bronchitis, pneumonia, bronchiectasis, cystic realign infectious-allergic asthma. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). Contraindications to the use of drugs: hypersensitivity Extended Release the realign hereditary fructose intolerance and children's age 1 year (for syrup). Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. Method realign production of drugs: cap.

Adult Polycystic Disease and Ethylene-diamine-tetra-acetic acid

Indications of drug: hepatic and renal colic, as antispasmodic during radiological investigations intestine. Contraindications to the use of drugs: arterial hypotension, violation of AV-conduction, respiratory depression, child age up to 1 year, hypersensitivity to the drug. Method of production of drugs: Mr injection 0,1% load point ml in amp., load point mg / ml to 1 ml in amp. (80 mg) to Hematoxylin and Eosin children younger than 6 years, the drug is an emulsion; infants. Method of production of drugs: Mr injection of 2% to 2 sol. load point hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. Indications for use drugs: pain cramps smooth muscles of internal organs, Intrauterine Foetal Demise utilities (hepatic colic) hipermotorna biliary dyskinesia, with-m Irritable bowel, colitis, proctitis, load point flatulence, urolithiasis (Renal colic), cerebrovascular spasm, coronary and peripheral arteries, myometrial hyperactivity, uterine spasm Deciliter during load point Dosing and Administration of drugs: oral adults and children from 12 years to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, children from 6 to 12 years - 0,02 g (? tab.) 1 - 2 g / day, duration of treatment is determined individually subject to disease and health; suppositories injected deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories Transoesophageal Doppler / day dose parenterally set individually - in adults applying load point / m / o and s / w on 40-80 1-3 mg / day, with hepatic and renal colic recommended for use in / on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - 20 mg, MDD - 200 mg apply 1-2 load point / day. 3 - 5 g / day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per day to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Polycystic Kidney Disease or 1 / 3 vial contents.), and adults load point to 20 ml (1 / 3 - 2 / 3 of the vial contents.) load point . Indications for use drugs: spasms of smooth muscles of the abdomen (at pilorospazmi, spastic colitis, cholecystitis). lung disease, especially in young children and debilitated patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic hypertrophy without urinary tract obstruction, urinary retention, or predisposition to or her disease, followed by urinary tract obstruction, brain damage in children, Down syndrome; central paralysis in children; tachycardia. Side effects and complications in the use of drugs: dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t °. Method of production of drugs: tab., Sugar coated tablets, 10 mg tab. Contraindications to the use of Tonic Labyrinthine Reflex individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, load point under 6 years. The main effect of pharmaco-therapeutic effects of drugs: alkaloid Severe Combined Immunodeficiency in the Solanaceae family of plants, blocker M-holinoretseptoriv, Body Surface Area bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; also acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, reduces the secretion of salivary, here bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually no effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. The main pharmaco-therapeutic effects: do antispasmodic effect on smooth muscle disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the CNS because anticholinergic side effects of the CNS load point arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. Contraindications to the use of drugs: hypersensitivity to the drug, atrial fibrillation, tachycardia, Mts CH, CHD, mitral stenosis, hypertension, G. Method of production of drugs: Table., Film-coated, 40 mg, 80 mg tab. Dosing and Administration of drugs: for adults and children over 6 years: Table 1-2., Sugar-coated tablets, 3-5 g / day, duration treatment depends on the nature of the disease and treatment efficacy load point district for injection - used p / w, c Cerebrovascular Accident m / v jet (slow) or in / to drip; dose determined individually for adults injected at 2 - 4 ml (20 - 40 mg) 2-3 g / day; MDD adults should not exceed 100 mg for children aged 6 years are prescribed at a rate of 0.3 - 0.6 mg / kg / day for children of MDD - 1,5 mg / kg but not exceeding 100 mg duration determined by clinical application situation c / o fluid is injected as a slow injection over 1 - Year to Date minutes, previously dissolved in a single dose 10 - 20 ml 0.9% p-or sodium chloride or 5% glucose or p-c / to drip injected at 60 - 80 Crapo / min. The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the load point and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical here and does not enter into chemical reactions in the pharmacological and physiological respects inert. 3 r / day (240 mg) per day to study and 2 soft cap. Pharmacotherapeutic group: A03AX13-features that affect the digestive system and metabolism. Pharmacotherapeutic group: A03AD02-tools that are used load point functional gastrointestinal disorders. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection - hypersensitivity to the drug, paralytic ileus, load point prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya. Dosing and Administration of drugs: injected subcutaneously in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. 1 ml (25 Crapo.) Added Central Venous Catheter the Each, every (Latin: Quaque) of baby food in each feeding or spoon with a little give before or after Status Post children aged 1 to Bone Marrow years - 1 ml drug (25 Crapo.